Abstract
The histamine H2-receptor antagonist metiamide is an inhibitor of endogenous and stimulated gastric-acid secretion. It appears to have therapeutic possibilities in duodenal-ulcer disease. Three patients exhibiting the Zollinger-Ellison syndrome have been treated with this drug for six months or more. Rapid symptomatic improvement occurred in each case, followed by ulcer healing. There were also reductions in gastric secretion and consistent changes in the fasting serum-gastrin concentration. One patient relapsed temporarily during therapy. There have been no side effects. It is concluded that, in the short term, metiamide is of benefit in the Zollinger-Ellison syndrome.
Similar content being viewed by others
References
Wilson SD, Ellison RM: Survival in patients treated by total gastrectomy. Ann Surg 111:787–791, 1966
Black JW, Duncan WAM, Durant CJ, Ganellin CR, Parsons EM: Definition and antagonism of histamine H2-receptors. Nature 236:385–390, 1972
Wyllie JH, Ealding WDP, Hesselbo T, Black JW: Inhibition of gastric secretion in man by Metiamide: A new, orally active histamine H2-receptor antagonist. Gut 14:424, 1973
Carter DC, Werner M, Forrest JAH, Heading RC, Park J, Shearman DJC: Effect of histamine H2-receptor blockade on vagally induced gastric secretion in man. Scott Med J 19:153, 1974
Thjodleifsson B, Wormsley KG: Gastric response to metiamide. Br Med J 2:304–306, 1974
Milton-Thompson GJ, Williams JG, Jenkins DJA, Misiewicz JJ: Inhibition of nocturnal acid secretion in duodenal ulcer by one oral dose of Metiamide. Lancet 1:693–4, 1974
Isenberg JI, Walsh JH, Passaro E, Jr, Grossman MI: The effect of secretin on serum gastrin, serum calcium and gastric acid secretion in a patient with Zollinger-Ellison Syndrome. Gastroenterology 62:626–631, 1972
Venables CW: An assessment of the value of measuring uncollected gastric secretion during routine secretion studies in man. Br J Surg 59:473–477, 1972
Venables CW: The value of a combined pentagastrin/insulin test in studies of stomal ulceration. Br J Surg 57:757–761, 1970
McGuigan JE: Immunochemical studies with synthetic human gastrin. Gastroenterology 54:1005–1011, 1968
Stadil F, Rehfeld JF: Preparation125I labelled synthetic human gastrin for radioimmunoassay. Scand J Clin Lab Invest 30:361–368, 1972
Hall R, Anderson J, Smart GA, Besser M: Fundamentals of clinical endocrinology. New York, Pitman Medical, 1974, pp 392–393
Thompson MH, Reed JD, Dale G, Venables CW: Early clinical experience with Metiamide, a histamine H2-receptor antagonist, in patients with duodenal ulcer. Am J Dig Dis 20(11), 1975
Everson TC: Nutrition following total gastrectomy, with particular reference to fat and protein assimilation. Int Abstr Surg 95:209–230, 1952
Crean GP, Marshall MW, Rumsey RDE: Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50, 123) To Rats. Gastroenterology 57:147–155, 1969
Halloran LG, Swank M, Haynes BW: Metiamide in Zollinger-Ellison Syndrome. Lancet 1:281, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blair, E.L., Grund, E.R., Miller, I.T. et al. Metiamide in the Zollinger-Ellison syndrome. Digest Dis Sci 20, 1123–1130 (1975). https://doi.org/10.1007/BF01070755
Issue Date:
DOI: https://doi.org/10.1007/BF01070755